Your HCP analysis should be both reactive to broader populations of HCPs and more specific to HCPs likely to be in the final product.
However, with current methods, based on 2D PAGE and Western Blot, it is difficult to know if both of these conditions are met.
Experience Ejvind Mortz present the NEW Alphalyse Coverage Analysis based on plate-based immunocapture combined with LC-MS, which provides all of the following:
✔️ List of HCPs recognized by ELISA antibodies
✔️ List of HCPs in mock or early process sample
✔️ HCP coverage
✔️ Specific HCP coverage of drug substance
Find out more
on the event site: